Eli Lilly begins clinical trial for COVID-19 antibody treatment
Monday, June 1, 2020 - 11:20
in Health & Medicine
U.S. pharma company Eli Lilly said Monday it's begun a trial of the first potential medicine specifically designed to attack SARS-CoV-2, the virus that causes COVID-19.